IPP Bureau
Thermo Fisher launches SpeciMAX saliva collection kit
By IPP Bureau - September 29, 2021
The kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses for safer sample collection
Shalby Hospitals teams up with Ganpat university to offer MBA in healthcare management
By IPP Bureau - September 29, 2021
The aspirant can enrol in MBA (Healthcare and Hospital Management) at Ganpat University, -Centre for Management Studies and Research, which will be facilitated by Ganpat University and Shalby Centre for Healthcare Management and Research
MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9
By IPP Bureau - September 29, 2021
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
Digital health-start-up MFine raises US $ 48 million
By IPP Bureau - September 29, 2021
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions
Zebra Medical Vision receives clearance for Coronary Artery Calcium (CAC) solution
By IPP Bureau - September 28, 2021
The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease
Eisai initiates rolling submission for Biological Licence Application of Lecanemab
By IPP Bureau - September 28, 2021
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer
By IPP Bureau - September 28, 2021
Prostate cancer is the second-most common cancer in men and despite an increase in the number of available treatments for men with mCRPC, five-year survival remains low
Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027
By IPP Bureau - September 28, 2021
One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports
Tavneos (avacopan) approved for ANCA associated vasculitis in Japan
By IPP Bureau - September 28, 2021
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
Larsen & Toubro Infotech partners with eClinicalHealth to accelerate clinical research
By IPP Bureau - September 28, 2021
As part of this strategic partnership, LTI with its digital, technical and life sciences domain capabilities, will help accelerate joint go-to-market pursuits and faster deployment for Clinpal Adopters
Zymo Research donates one million Covid-19 test kits to Mapmygenome
By IPP Bureau - September 28, 2021
Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries
SpeeDx and SynGenis partner for custom oligonucleotide synthesis
By IPP Bureau - September 28, 2021
The investment will increase SpeeDx internal capacity to scale up manufacturing
Bal Pharma ramps up API capacity of Gliclazide
By IPP Bureau - September 28, 2021
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
Sun Pharma launches novel cough medicine
By IPP Bureau - September 28, 2021
Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug
B2B pharma start-up MEDdelivery raises US $ 1 million
By IPP Bureau - September 28, 2021
The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months
